These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1364 related items for PubMed ID: 22465546

  • 1. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S, Chen T, Chen R, Hu Y, Chen M, Wang Y.
    Int J Pharm; 2012 Jul 01; 430(1-2):238-46. PubMed ID: 22465546
    [Abstract] [Full Text] [Related]

  • 2. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study.
    Chen R, Wang S, Zhang J, Chen M, Wang Y.
    Drug Deliv; 2015 Jul 01; 22(5):666-74. PubMed ID: 24512431
    [Abstract] [Full Text] [Related]

  • 3. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y, Pan J, Feng SS.
    Int J Pharm; 2010 Aug 16; 395(1-2):243-50. PubMed ID: 20472049
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
    You J, Wan F, de Cui F, Sun Y, Du YZ, Hu FQ.
    Int J Pharm; 2007 Oct 01; 343(1-2):270-6. PubMed ID: 17706383
    [Abstract] [Full Text] [Related]

  • 5. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J, Gong T, Wang C, Zhong Z, Zhang Z.
    Int J Pharm; 2007 Aug 01; 340(1-2):153-62. PubMed ID: 17428627
    [Abstract] [Full Text] [Related]

  • 6. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.
    Lee MK, Lim SJ, Kim CK.
    Biomaterials; 2007 Apr 01; 28(12):2137-46. PubMed ID: 17257668
    [Abstract] [Full Text] [Related]

  • 7. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D, Ahuja A, Velpandian T, Lather V, Dutta T, Khar RK.
    Pharmazie; 2009 May 01; 64(5):301-10. PubMed ID: 19530440
    [Abstract] [Full Text] [Related]

  • 8. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K, Reddy H, Murthy RS.
    AAPS PharmSciTech; 2007 Oct 12; 8(4):E83. PubMed ID: 18181544
    [Abstract] [Full Text] [Related]

  • 9. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N, Veerabrahma K.
    Drug Deliv; 2016 Oct 12; 23(2):395-404. PubMed ID: 24865287
    [Abstract] [Full Text] [Related]

  • 10. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
    Mukherjee S, Ray S, Thakur RS.
    Pak J Pharm Sci; 2009 Apr 12; 22(2):131-8. PubMed ID: 19339221
    [Abstract] [Full Text] [Related]

  • 11. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH, Wu CT, Fang JY.
    Drug Dev Ind Pharm; 2010 Jul 12; 36(7):751-61. PubMed ID: 20136495
    [Abstract] [Full Text] [Related]

  • 12. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y.
    Int J Pharm; 2012 Jan 17; 422(1-2):390-7. PubMed ID: 22001531
    [Abstract] [Full Text] [Related]

  • 13. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.
    Guo X, Xing Y, Mei Q, Zhang H, Zhang Z, Cui F.
    Anticancer Drugs; 2012 Feb 17; 23(2):185-90. PubMed ID: 22027535
    [Abstract] [Full Text] [Related]

  • 14. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J, Wang Q, Zhou X, Zhang N.
    Int J Pharm; 2008 Mar 20; 352(1-2):273-9. PubMed ID: 18054182
    [Abstract] [Full Text] [Related]

  • 15. [Preparation and characterization of solid lipid nanoparticles of norcantharidin].
    Tian HY, Zhai GX.
    Zhong Yao Cai; 2007 Sep 20; 30(9):1146-8. PubMed ID: 18236763
    [Abstract] [Full Text] [Related]

  • 16. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M, Nazemiyeh H.
    Eur J Pharm Sci; 2014 Aug 01; 59():49-57. PubMed ID: 24768857
    [Abstract] [Full Text] [Related]

  • 17. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S, Ng WK, Tan RB.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):139-51. PubMed ID: 22664358
    [Abstract] [Full Text] [Related]

  • 18. Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
    Laserra S, Basit A, Sozio P, Marinelli L, Fornasari E, Cacciatore I, Ciulla M, Türkez H, Geyikoglu F, Di Stefano A.
    Int J Pharm; 2015 May 15; 485(1-2):183-91. PubMed ID: 25747452
    [Abstract] [Full Text] [Related]

  • 19. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice.
    Lou H, Gao L, Wei X, Zhang Z, Zheng D, Zhang D, Zhang X, Li Y, Zhang Q.
    Colloids Surf B Biointerfaces; 2011 Oct 15; 87(2):319-25. PubMed ID: 21676599
    [Abstract] [Full Text] [Related]

  • 20. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS, Cho CW.
    J Pharm Pharmacol; 2013 Jan 15; 65(1):72-8. PubMed ID: 23215690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.